Therefore, we provide an underlying mechanism of CDDO-Me for mitochondrial fission independent of LONP1 activity, and propose the availability of CDDO-Me for various neurological diseases relating to aberrant mitochondrial dynamics. This evidence concerns the gene LONP1 and nervous system disorder.